Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients [Phase 2, Phase 3]
A clinical trial update comparing consolidation regimens of IDA with intermediate-dose cytarabine versus intermediate-dose cytarabine alone …
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001) [Phase 2, Phase 3]
A clinical trial update for CD123/CLL1 CAR-T cells in relapsed/refractory acute myeloid leukemia (AML) in Phase 2/Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial of a liposome-encapsulated combination therapy for younger patients with relapsed or refractory acute myeloid leukemia, comp…
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 open-label study evaluating safety and efficacy of two doses of quizartinib in relapsed or refractory acute myeloid leukemia has com…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Home Away From Home - Medical Outcomes
Completed clinical trial update for a study involving acute myeloid leukemia and neutropenia with mention of bacteremia results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Home Away From Home - Quality of Life Surveys
A completed clinical trial focusing on quality of life surveys in pediatric patients with acute myeloid leukemia; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia. [Phase 2]
A Phase 2 clinical trial assessing safety, efficacy, and pharmacodynamics of azacitidine in children and young adults with acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases [Phase 2]
Phase 2 trial update on NK cell–based non-myeloablative transplantation for acute myeloid diseases, including acute myeloid leukemia and mye…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections [Phase 4]
Phase 4 clinical trial update reporting pharmacokinetics of posaconazole (Noxafil) when used as prophylaxis for invasive fungal infections i…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation. [Phase 2]
Phase 2 clinical trial evaluating azacytidine and lymphocytes in relapse of acute myeloid leukemia or myelodysplastic syndrome after allogen…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 2]
Phase 2 trial investigating sirolimus, cyclosporine, and mycophenolate mofetil to prevent graft-versus-host disease in patients with blood c…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial results update for AC220 in treating Acute Myeloid Leukemia has been completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy [Phase 2]
Phase 2 clinical trial investigating an exercise program for patients with acute myeloid leukemia undergoing induction chemotherapy has comp…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial evaluating PLX3397 in adults with relapsed or refractory acute myeloid leukemia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Clinical trial update for Entospletinib as monotherapy and in combination with chemotherapy in adults with Acute Myeloid Leukemia; the study…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
A completed clinical trial comparing allogeneic hematopoietic cell transplantation to chemotherapy in older AML patients, with results poste…
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating daunorubicin hydrochloride, cytarabine, and nilotinib in newly diagnosed adult acute myeloid leukemia has been co…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Phase I/II Study of DFP-10917 in Patients With Acute Leukemia [Phase 1, Phase 2]
Phase I/II clinical trial update for DFP-10917 in acute leukemia (AML and ALL) has been completed.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing management of platelet transfusion therapy in patients with blood cancers or treatment-induced thrombocytop…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation [Phase 3]
Phase 3 study comparing ASP2215 (gilteritinib) to salvage chemotherapy in adults with relapsed or refractory FLT3-mutated acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia [Phase 1, Phase 2]
A clinical trial evaluating interleukin-21 expanded natural killer cells for induction therapy in acute myeloid leukemia (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.